Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Retained Earnings: 2011-2025

Historic Retained Earnings for Adma Biologics (ADMA) over the last 11 years, with Sep 2025 value amounting to -$211.0 million.

  • Adma Biologics' Retained Earnings rose 49.81% to -$211.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$211.0 million, marking a year-over-year increase of 49.81%. This contributed to the annual value of -$308.6 million for FY2024, which is 39.05% up from last year.
  • Adma Biologics' Retained Earnings amounted to -$211.0 million in Q3 2025, which was up 14.72% from -$247.5 million recorded in Q2 2025.
  • Over the past 5 years, Adma Biologics' Retained Earnings peaked at -$211.0 million during Q3 2025, and registered a low of -$506.3 million during Q4 2023.
  • Its 3-year average for Retained Earnings is -$398.6 million, with a median of -$456.4 million in 2024.
  • Per our database at Business Quant, Adma Biologics' Retained Earnings dropped by 26.37% in 2021 and then spiked by 49.81% in 2025.
  • Over the past 5 years, Adma Biologics' Retained Earnings (Quarterly) stood at -$412.1 million in 2021, then fell by 15.99% to -$478.0 million in 2022, then decreased by 5.91% to -$506.3 million in 2023, then soared by 39.05% to -$308.6 million in 2024, then surged by 49.81% to -$211.0 million in 2025.
  • Its Retained Earnings was -$211.0 million in Q3 2025, compared to -$247.5 million in Q2 2025 and -$281.7 million in Q1 2025.